1. Weihua Ren, Fengchun Wang, Lei Sun, et al. Role of autologous platelet-rich plasma in the treatment of femoral neck fractures, JCEM 2016 ISSN: 1940-5901/IJCEM0023518;
2. Samy AM. The role of platelet-rich plasma in the management of fracture neck femur: new insights. Int Orthop 2016; 40: 1019-24. https://doi.org/10.1007/s00264-015-2844-1;
3. Griffin XL, Achten J, Parsons N, et al. Plateletrich therapy in the treatment of patients with hip fractures: a single Centre, parallel group, participantblinded, randomized controlled trial. BMJ Open 2013;3:e002583.doi:10.1136/bmjopen-2013-002583 https://doi.org/10.1136/bmjopen-2013-002583;
4. Singer BR, McLauchlan GJ, Robinson CM, et al. Epidemiology of fractures in 15,000 adults: The influence of age and gender. J Bone Joint Surg Br 1998; 80 (2):243-8. https://doi.org/10.1302/0301-620X.80B2.7762;
5. Dennison E, Mohamed MA, Cooper C. Epidemiology of osteoporosis. Rheum Dis Clin North Am 2006; 32 (4):617-29. https://doi.org/10.1016/j.rdc.2006.08.003;